[HTML][HTML] Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction

AJ Moss, W Zareba, WJ Hall, H Klein… - … England Journal of …, 2002 - Mass Medical Soc
Background Patients with reduced left ventricular function after myocardial infarction are at
risk for life-threatening ventricular arrhythmias. This randomized trial was designed to …

Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria

…, JA Towbin, A Tsatsopoulou, T Wichter, W Zareba - Circulation, 2010 - Am Heart Assoc
Background— In 1994, an International Task Force proposed criteria for the clinical diagnosis
of arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) that facilitated …

[HTML][HTML] Cardiac-resynchronization therapy for the prevention of heart-failure events

…, SD Solomon, D Wilber, W Zareba - … England Journal of …, 2009 - Mass Medical Soc
Background This trial was designed to determine whether cardiac-resynchronization therapy
(CRT) with biventricular pacing would reduce the risk of death or heart-failure events in …

Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias

…, P Brink, AAM Wilde, L Toivonen, W Zareba… - Circulation, 2001 - Am Heart Assoc
Background—The congenital long-QT syndrome (LQTS) is caused by mutations on several
genes, all of which encode cardiac ion channels. The progressive understanding of the …

[HTML][HTML] Reduction in inappropriate therapy and mortality through ICD programming

…, M Shoda, D Wilber, W Zareba - … England Journal of …, 2012 - Mass Medical Soc
Background The implantable cardioverter–defibrillator (ICD) is highly effective in reducing
mortality among patients at risk for fatal arrhythmias, but inappropriate ICD activations are …

Effectiveness and limitations of β-blocker therapy in congenital long-QT syndrome

AJ Moss, W Zareba, WJ Hall, PJ Schwartz… - Circulation, 2000 - Am Heart Assoc
Background—β-blockers are routinely prescribed in congenital long-QT syndrome (LQTS),
but the effectiveness and limitations of β-blockers in this disorder have not been evaluated. …

Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact

JP Daubert, W Zareba, DS Cannom, S McNitt… - Journal of the American …, 2008 - jacc.org
Objectives : This study sought to identify the incidence and outcome related to inappropriate
implantable cardioverter-defibrillator (ICD) shocks, that is, those for nonventricular …

Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation

…, V Menon, GJ Philippides, DM Roden, W Zareba - Circulation, 2010 - Am Heart Assoc
however, this characteristic twisting morphology may not be evident in all ECG leads. Second,
episodes of drug-induced TdP usually start with a short-long-short pattern of RR cycles …

Effectiveness of cardiac resynchronization therapy by QRS morphology in the multicenter automatic defibrillator implantation trial–cardiac resynchronization therapy …

W Zareba, H Klein, I Cygankiewicz, WJ Hall, S McNitt… - Circulation, 2011 - Am Heart Assoc
Background— This study aimed to determine whether QRS morphology identifies patients
who benefit from cardiac resynchronization therapy with a defibrillator (CRT-D) and whether it …

[HTML][HTML] Influence of the genotype on the clinical course of the long-QT syndrome

W Zareba, AJ Moss, PJ Schwartz… - … England Journal of …, 1998 - Mass Medical Soc
Background The congenital long-QT syndrome, caused by mutations in cardiac potassium-channel
genes (KVLQT1 at the LQT1 locus and HERG at the LQT2 locus) and the sodium-…